Interim pathway before Part D rollout
Ahead of the BALANCE Model, CMS is implementing a separate bridge program to provide short-term access to medications. Under the Medicare GLP-1 Bridge, eligible beneficiaries can receive obesity drugs between July 1 and Dec. 31, 2026, outside the Part D system.
